Cost-effectiveness of pembrolizumab for treatment of platinum-resistant recurrent or metastatic head and neck squamous cell carcinoma in China: an economic analysis based on a rand...

by Wenxiu Xin, Qilu Fang, Yinghui Tong, Gaoqi Xu, Guonong Yang
Published 2020-12-01

Cost effectiveness of immune checkpoint inhibitors for treatment of non-small cell lung cancer: A systematic review.

by Haiying Ding, Wenxiu Xin, Yinghui Tong, Jiao Sun, Gaoqi Xu, Ziqi Ye, Yuefeng Rao
Published 2020-01-01